Abivax (ABVX) Interest Coverage Ratio (2024 - 2026)
Abivax (ABVX) recorded quarterly Interest Coverage Ratio of 11.79 in Q1 2026, up 3623.05% quarter-over-quarter from 0.33 in Q4 2025, and up 67.94% on a YoY basis from 7.02 in Q1 2025.
Abivax (ABVX) Interest Coverage Ratio (2024 - 2026) Analysis & Trends
Abivax's Interest Coverage Ratio history runs 3 years deep, the most recent figure standing at 11.79 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 67.94% year-over-year to 11.79; the TTM figure through Mar 2026 stood at 2.3 (up 85.43% YoY), while the FY2025 annual figure was 2.2, up 78.37% from the prior year.
- Interest Coverage Ratio was 11.79 for Q1 2026 at Abivax, up from 0.33 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 11.79 in Q1 2026 to a low of 1.27 in Q4 2024.
- Historically, Interest Coverage Ratio has averaged 5.35 across 3 years, with a median of 5.92 in 2024.
- Biggest YoY gain for Interest Coverage Ratio was 73.72% in 2025; the steepest drop was 85.35% in 2025.
- A 3-year view of Interest Coverage Ratio shows it stood at 1.27 in 2024, then soared by 73.72% to 0.33 in 2025, then surged by 3623.05% to 11.79 in 2026.
- The last three Interest Coverage Ratio figures came in at 11.79 (Q1 2026), 0.33 (Q4 2025), and 0.87 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -258.33 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 11.79 |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 49.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.79 |
| Dec 31, 2025 | -0.33 |
| Sep 30, 2025 | 0.87 |
| Jun 30, 2025 | 8.59 |
| Mar 31, 2025 | 7.02 |
| Dec 31, 2024 | -1.27 |
| Sep 30, 2024 | 5.92 |
| Jun 30, 2024 | 5.01 |
| Mar 31, 2024 | 10.57 |